IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Teva Pharmaceutical Finance Netherlands III BV

Q3 2025 vs Q4 2025

Comparing institutional holders between quarters

Quarters

Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile
Pacer Advisors, Inc.
INCREASED
Shares100,000 from 80,000
Change+20,000 (+25%)
Value$101.0K (+$20.6K)
Filed 2026-02-24
Saranac Partners Ltd
CLOSED
Shares0 from 400,000
Change-400,000 (-100%)
Value$0 (-$410.2K)
Filed 2026-02-06
Status
Pacer Advisors, Inc.
INCREASED100,00080,000+20,000+25%$80.4K$101.0K+$20.6K2026-02-24
Saranac Partners Ltd
CLOSED0400,000-400,000-100%$410.2K$0-$410.2K2026-02-06
Showing 2 of 2 institutions